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Proteases commit microbicide
 
hite blood cells use proteases to kill their targets, according 
to new results from Emer Reeves, Hiu Lu, Anthony Segal 
(University College, London, England), and colleagues. The 
findings contradict previously accepted notions that reactive 
oxygen species (ROSs) are the killing agents.
ROSs like superoxide are produced by NADPH oxidase 
activity when white blood cells, primarily neutrophils, 
phagocytose pathogens. For decades it has been thought that 
high concentrations of the toxic ROSs resulting from this 
respiratory burst are directly responsible for killing micro-
organisms. But the new results prove otherwise.
Segal’s group showed that mice deficient in protease activity 
have increased sensitivity to microbes. Additionally, purified 
neutrophils from the protease-deficient mice are impaired in 
their antimicrobial activity in vitro. “Our results are conclusive,” 
says Segal. “By taking out the proteases, we do not interfere 
with the respiratory burst, but do interfere with killing.”
The proteases are activated 
through increases in both pH 
and hypertonicity in the 
phagocytotic vacuoles. These 
changes arise when NADPH 
oxidase activity drives electrons 
into the vacuole. To compensate 
for the charge transfer across the 
membrane, K
 
 
 
 also enters. The 
resulting hypertonic conditions 
release the cationic proteases 
from their bound state on an 
anionic proteoglycan matrix. K
 
 
 
 entry also results in alkaline 
conditions that stimulate protease activity. The proteases are 
then free to bind to and digest the target microbes.
 
 
 
 
 
Reference:  Reeves, E., et al. 2002. 
 
Nature.
 
 416:291–297.
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Neutrophils kill engulfed 
microbes (white) using 
proteases.
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Trafﬁc jam suppresses immunity
 
rgan rejection in transplant patients can be prevented using 
the drug FTY720, but the drug’s mechanism of action has 
been unknown. Now, Suzanne Mandala, Hugh Rosen, and 
colleagues (Merck Research Laboratories, Rahway, NJ) show 
that it acts by retaining lymphocytes in lymph nodes, preventing 
their circulation through the bloodstream.
 
 
 
B and T lymphocytes are either 
retained in lymph nodes in order 
to contact antigens and antigen-
presenting cells or sent back out into 
the bloodstream for circulation. 
Circulating lymphocytes may enter 
tissues, where they mediate protective 
activities or cause tissue damage. 
Most immunosuppressive drugs 
work by inhibiting lymphocyte 
function: they either kill the cells directly, inhibit their production, 
or block signals downstream of antigen recognition. But FTY720 
works in a novel manner.
Rosen’s group found that a phosphate ester metabolite of 
FTY720 mimics the natural lipid sphingosine-1-phosphate 
(S1P) and binds several forms of S1P receptors. Activation of the 
receptors causes the sequestration of lymphocytes at nodes and a 
corresponding decrease in circulating lymphocytes. “This is the 
first indication that S1P and its receptors regulate lymphocyte 
trafficking and that, if manipulated pharmacologically, [they] 
can give rise to immunosuppression,” says Rosen. Unlike S1P, 
the side effects of which include low blood pressure, FTY720 is 
better tolerated in clinical use. The reasons behind this distinction 
are yet unclear, but may involve the failure of FTY720 to bind all 
S1P receptors. 
 
 
 
Reference:
 
Mandala, S., et al. 2002. 
 
Science
 
. 10.1126/science.1070238
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FTY720 causes lympho-
cytes to get trapped in 
nodes (bracket).
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Learning by palmitoylation
 
earning is probably driven by use-
dependent changes in synaptic 
strength. Now, Alaa El-Husseini, David 
Bredt (University of California at San 
Francisco, San Francisco, CA), and 
colleagues have identified regulated protein 
palmitoylation as one means to control 
the strength of synapse responses.
Synaptic activity is controlled by 
AMPA channels, which respond to the 
neurotransmitter glutamate by letting in 
Na
 
 
 
 until the neuron fires. Ca
 
2
 
 
 
 influx 
through NMDA receptors (also activated 
by glutamate) alters synaptic responses by 
influencing the number of AMPA receptors 
clustered at the synapse.
It now appears that protein palmitoylation 
is key to this modulation. The localization 
L
 
of AMPA receptors is controlled by the 
PDZ domain protein PSD-95, which also 
clusters at synapses and binds to the AMPA-
trafficking protein stargazin. The clustering 
of PSD-95 is known to require its 
palmitoylation. Now, Bredt and colleagues 
demonstrate that increased glutamate
receptor activity accelerates depalmitoylation 
of PSD-95 and that depalmitoylation 
causes endocytosis and dispersion of both 
PSD-95 and AMPA receptors, leading to 
depression of synaptic strength.
“This defines a mechanism for activity-
dependent changes in AMPA receptor 
numbers and defines protein palmitoylation 
as a new signaling mechanism at 
synapses,” says Bredt. The enzymes that 
add and remove PSD-95 palmitoyl groups 
have not been identified, but Bredt 
speculates that they will be Ca
 
2
 
 
 
 regulated, 
as Ca
 
2
 
 
 
 entry into the cell (e.g., through 
NMDA receptors) is required for AMPA 
dispersion. 
 
 
 
Reference: 
 
El-Husseini, A., et al. 2002. 
 
Cell.
 
108:849–863.
Clusters of AMPA receptors (red spots) 
disperse when PSD-95 palmitoylation is 
blocked (right).
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From migration to circulation
 
Pressured into making a kidney
 
pathway required for blood vessel development in 
vertebrates also functions in flies, according to new results 
from Nam Cho, Mark Krasnow (Stanford University, Stanford,  A
 
CA), and colleagues. The results imply 
that cell migration, not angiogenesis, 
may have been the original function 
of the vascular endothelial growth 
factor receptor (VEGFR) tyrosine 
kinase family and its ligands.
The active migration of blood 
cells, or hemocytes, occurs during fly 
embryogenesis when the heart has 
not yet begun pumping. Fly blood 
does not travel through a closed 
circulatory system, but Cho found 
that flies have homologues of the 
VEGF pathway, which is required for 
vertebrate blood vessel development. 
This suggests that the proteins have a 
more ancient function.
Blood cells (red) do not migrate when VEGFR is 
missing (bottom).
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That function appears to be the migration of blood cells 
during embryogenesis, according to the new study. Cho 
and colleagues found that, in flies lacking VEGFR, blood 
cells differentiate, but do not migrate normally and aggregate 
in the anterior of the embryo. Inactivation of all three 
 
evelopmental biologists spend a great 
deal of time studying molecular 
signals that determine the when and 
where of organogenesis. But recent results 
indicate they may be overlooking 
something. Mechanical forces provided 
by the vasculature are also at work, according 
D
 
to a new study by Fabrizio Serluca, 
Ian Drummond, and Mark Fishman 
(Harvard Medical School, Boston, MA), 
who examine the development of the 
zebrafish kidney glomerulus.
The glomerulus is made up of unique 
layers of vessel endothelium that filter fluid 
from the blood without removing proteins 
or cells. Fluid flows between the endothelial 
cells, before moving sequentially through 
the basement membrane of the kidney and 
epithelial cells known as podocytes, and 
finally into the tubules of the kidney. 
During zebrafish embryogenesis, the 
podocytes form the glomerulus by migrating 
and coalescing to an area surrounding a 
vessel outgrowth of the aorta.
Now, it seems that mechanical forces 
from these vessel endothelium cells initiate 
podocyte cell migration. Fishman’s group 
identified multiple mutants with disrupted 
glomerular assembly, each of which shares 
the common feature of impaired circulation. 
The group showed that hemodynamic 
MMP-2 blockage (bottom) stops glom-
erulus formation by podocytes (blue).
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forces from the aorta are essential for 
glomerular development by stimulating 
podocyte migration. “Cell fate in the 
mutants is normal; only organogenesis 
is affected,” says Fishman. “The cells just 
don’t get together as they should.”
This force-initiated podocyte migration 
requires the collagen-degrading enzyme 
matrix metalloproteinase-2 (MMP-2). 
MMP-2 may be turned on by stretch-
sensitive ion channels or by some other 
stretch-sensitive signal transduction 
pathway. In turn, MMP-2 may allow 
the vessels to migrate more easily into the 
epithelium by disrupting extracellular 
collagen. Alternatively, MMP-2 may 
activate matrix stores of inactive vessel-
promoting signals. Homologues of the 
zebrafish signals may be involved in 
human disorders caused by hemodynamic 
forces, including atherosclerosis resulting 
from high blood pressure. 
 
 
 
Reference: 
 
Serluca, F., et al. 2002. 
 
Curr.
Biol.
 
 12:492–497. 
 
homologues of the VEGF ligand resulted in the same cell 
migration defect. Ectopic expression of a VEGF ligand caused 
misrouting of blood cells, suggesting that it may act as a 
chemoattractant to assure that the 
hemocytes travel along pathways 
where phagocytosis of apoptotic 
cells is required.
Blood cell chemoattractant activity 
has also been demonstrated in vitro 
for a vertebrate VEGF, but has largely 
been ignored. “While most of the 
press for VEGF involves its role in 
angiogenesis
 
…
 
it may have originally 
evolved for blood cell functions,” says 
Cho. However, it is not known whether 
the vertebrate homologues still serve 
similar functions in blood cells. The 
simple genetics of the fly system 
should facilitate the identification 
of signaling molecules downstream 
of VEGF, which may aid in the discovery of therapeutic agents 
for blocking angiogenesis during tumor growth or increasing 
vascular growth after injuries such as heart attack.
 
 
 
 
 
Reference:  Cho, N., et al. 2002. 
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